The effect of chemotherapy on the in vivo frequency of glycophorin A ‘null’ variant erythrocytes

This publication has 9 references indexed in Scilit:

• EVIDENCE FOR AN ELEVATED FREQUENCY OF INVIVO SOMATIC-CELL MUTATIONS IN ATAXIA TELANGIECTASIA
  1989
• Evidence for increased in vivo mutation and somatic recombination in Bloom's syndrome.
  Proceedings of the National Academy of Sciences, 1989
• Induction of specific-locus and dominant-lethal mutations by cyclophosphamide and combined cyclophosphamide-radiation treatment in male mice
  Mutation Research - Fundamental and Molecular Mechanisms of Mutagenesis, 1988
• Mutagenicity monitoring in humans by autoradiographic assay for mutant T lymphocytes
  Mutation Research/Genetic Toxicology, 1988
• Evidence for Increased Somatic Cell Mutations at the Glycophorin A Locus in Atomic Bomb Survivors
  Science, 1987
• Measurements of the frequency of human erythrocytes with gene expression loss phenotypes at the glycophorin A locus
  Human Genetics, 1986
• INCREASED MUTATION FREQUENCY FOLLOWING TREATMENT WITH CANCER-CHEMOTHERAPY
  1985
• Risk of Leukemia Associated With the First Course of Cancer Treatment: An Analysis of the Surveillance, Epidemiology, and End Results Program Experience2
  JNCI Journal of the National Cancer Institute, 1984
• Activation of cyclophosphamide in man and animals
  Cancer, 1971